• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项关于颅底软骨肉瘤放射治疗和粒子束治疗的系统评价与荟萃分析:TRP-软骨肉瘤2024。

A systematic review and meta-analysis of radiotherapy and particle beam therapy for skull base chondrosarcoma: TRP-chondrosarcoma 2024.

作者信息

Nakamura Masatoshi, Mizumoto Masashi, Saito Takashi, Shimizu Shosei, Li Yinuo, Oshiro Yoshiko, Inaba Masako, Hosaka Sho, Fukushima Hiroko, Suzuki Ryoko, Iizumi Takashi, Nakai Kei, Maruo Kazushi, Sakurai Hideyuki

机构信息

Department of Radiation Oncology, University of Tsukuba, Tsukuba, Japan.

Department of Pediatric Radiation Therapy Center/Pediatric Proton Beam Therapy Center, Hebei Yizhou Cancer Hospital, Zhuozhou, China.

出版信息

Front Oncol. 2024 Mar 19;14:1380716. doi: 10.3389/fonc.2024.1380716. eCollection 2024.

DOI:10.3389/fonc.2024.1380716
PMID:38567162
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10985235/
Abstract

INTRODUCTION

Chondrosarcoma is a rare malignant bone tumor. Particle beam therapy (PT) can concentrate doses to targets while reducing adverse events. A meta-analysis based on a literature review was performed to examine the efficacy of PT and photon radiotherapy for skull base chondrosarcoma.

METHODS

The meta-analysis was conducted using 21 articles published from 1990 to 2022.

RESULTS

After PT, the 3- and 5-year overall survival (OS) rates were 94.1% (95% confidence interval [CI]: 91.0-96.2%) and 93.9% (95% CI: 90.6-96.1%), respectively, and the 3- and 5-year local control rates were 95.4% (95% CI: 92.0-97.4%) and 90.1% (95% CI: 76.8-96.0%), respectively. Meta-regression analysis revealed a significant association of PT with a superior 5-year OS rate compared to three-dimensional conformal radiotherapy (p < 0.001). In the studies used in the meta-analysis, the major adverse event of grade 2 or higher was temporal lobe necrosis (incidence 1-18%, median 7%).

CONCLUSION

PT for skull base chondrosarcoma had a good outcome and may be a valuable option among radiotherapy modalities. However, high-dose postoperative irradiation of skull base chondrosarcoma can cause adverse events such as temporal lobe necrosis.

摘要

引言

软骨肉瘤是一种罕见的恶性骨肿瘤。粒子束治疗(PT)可将剂量集中于靶区,同时减少不良事件。基于文献综述进行了一项荟萃分析,以研究PT和光子放疗对头颈部软骨肉瘤的疗效。

方法

使用1990年至2022年发表的21篇文章进行荟萃分析。

结果

PT治疗后,3年和5年总生存率(OS)分别为94.1%(95%置信区间[CI]:91.0-96.2%)和93.9%(95%CI:90.6-96.1%),3年和5年局部控制率分别为95.4%(95%CI:92.0-97.4%)和90.1%(95%CI:76.8-96.0%)。荟萃回归分析显示,与三维适形放疗相比,PT与更高的5年OS率显著相关(p<0.001)。在荟萃分析中使用的研究中,2级或更高等级的主要不良事件是颞叶坏死(发生率1-18%,中位数7%)。

结论

PT治疗头颈部软骨肉瘤效果良好,可能是放疗方式中的一个有价值的选择。然而,头颈部软骨肉瘤术后高剂量照射可导致颞叶坏死等不良事件。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7955/10985235/07276277b324/fonc-14-1380716-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7955/10985235/1b699c84d1f8/fonc-14-1380716-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7955/10985235/438a1fe98d38/fonc-14-1380716-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7955/10985235/07276277b324/fonc-14-1380716-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7955/10985235/1b699c84d1f8/fonc-14-1380716-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7955/10985235/438a1fe98d38/fonc-14-1380716-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7955/10985235/07276277b324/fonc-14-1380716-g003.jpg

相似文献

1
A systematic review and meta-analysis of radiotherapy and particle beam therapy for skull base chondrosarcoma: TRP-chondrosarcoma 2024.一项关于颅底软骨肉瘤放射治疗和粒子束治疗的系统评价与荟萃分析:TRP-软骨肉瘤2024。
Front Oncol. 2024 Mar 19;14:1380716. doi: 10.3389/fonc.2024.1380716. eCollection 2024.
2
Systematic Review and Meta-Analysis of Particle Beam Therapy versus Photon Radiotherapy for Skull Base Chordoma: TRP-Chordoma 2024.粒子束治疗与光子放疗治疗颅底脊索瘤的系统评价和Meta分析:TRP-脊索瘤2024
Cancers (Basel). 2024 Jul 17;16(14):2569. doi: 10.3390/cancers16142569.
3
Long-term outcomes and prognostic factors of skull-base chondrosarcoma patients treated with pencil-beam scanning proton therapy at the Paul Scherrer Institute.保罗·谢尔研究所采用笔形束扫描质子治疗的颅底软骨肉瘤患者的长期结局及预后因素
Neuro Oncol. 2016 Feb;18(2):236-43. doi: 10.1093/neuonc/nov154. Epub 2015 Aug 30.
4
Efficacy and Safety of Adjuvant Proton Therapy Combined With Surgery for Chondrosarcoma of the Skull Base: A Retrospective, Population-Based Study.辅助质子治疗联合手术治疗颅底软骨肉瘤的疗效和安全性:一项回顾性、基于人群的研究。
Int J Radiat Oncol Biol Phys. 2016 May 1;95(1):312-321. doi: 10.1016/j.ijrobp.2015.12.016. Epub 2015 Dec 17.
5
Results of spot-scanning proton radiation therapy for chordoma and chondrosarcoma of the skull base: the Paul Scherrer Institut experience.颅底脊索瘤和软骨肉瘤的点状扫描质子放射治疗结果:保罗·谢尔研究所的经验
Int J Radiat Oncol Biol Phys. 2005 Oct 1;63(2):401-9. doi: 10.1016/j.ijrobp.2005.02.023.
6
Proton therapy with a fixed beamline for skull-base chordomas and chondrosarcomas: outcomes and toxicity.质子治疗固定束线治疗颅底脊索瘤和软骨肉瘤:结果和毒性。
Radiat Oncol. 2021 Dec 20;16(1):238. doi: 10.1186/s13014-021-01961-9.
7
Long term outcomes of patients with skull-base low-grade chondrosarcoma and chordoma patients treated with pencil beam scanning proton therapy.采用笔形束扫描质子治疗的颅底低度软骨肉瘤和脊索瘤患者的长期疗效。
Radiother Oncol. 2016 Jul;120(1):169-74. doi: 10.1016/j.radonc.2016.05.011. Epub 2016 May 28.
8
High control rate in patients with chondrosarcoma of the skull base after carbon ion therapy: first report of long-term results.颅底软骨肉瘤患者接受碳离子治疗后的高控制率:长期结果的首次报告。
Cancer. 2014 May 15;120(10):1579-85. doi: 10.1002/cncr.28606. Epub 2014 Feb 5.
9
Patterns of Temporal Lobe Reaction and Radiation Necrosis after Particle Radiotherapy in Patients with Skull Base Chordoma and Chondrosarcoma-A Single-Center Experience.颅底脊索瘤和软骨肉瘤患者粒子放疗后颞叶反应及放射性坏死模式——单中心经验
Cancers (Basel). 2024 Feb 8;16(4):718. doi: 10.3390/cancers16040718.
10
Risk Factors for Radiation Necrosis and Local Recurrence after Proton Beam Therapy for Skull Base Chordoma or Chondrosarcoma.质子束治疗颅底脊索瘤或软骨肉瘤后放射性坏死和局部复发的危险因素
Cancers (Basel). 2023 Dec 1;15(23):5687. doi: 10.3390/cancers15235687.

引用本文的文献

1
A systematic review and meta-analysis of x-ray therapy versus proton beam therapy for pediatric central nervous system germ cell tumors: TRP-Germinoma 2025.针对儿童中枢神经系统生殖细胞肿瘤的X射线治疗与质子束治疗的系统评价和荟萃分析:TRP-生殖细胞瘤2025。
Int J Clin Oncol. 2025 Aug 21. doi: 10.1007/s10147-025-02863-6.
2
Role of Particle Therapy for Intrahepatic Cholangiocarcinoma; Meta-Analysis for Comparison with Standard Therapy: TRP-Intrahepatic Cholangiocarcinoma 2025.粒子治疗在肝内胆管癌中的作用;与标准治疗比较的荟萃分析:TRP-肝内胆管癌2025
Liver Cancer. 2025 Jun 22. doi: 10.1159/000546559.
3
Systematic Review and Meta-Analysis of Proton Beam Therapy Versus Photon Radiotherapy for Medulloblastoma: TRP-Medulloblastoma 2025.

本文引用的文献

1
Risk Factors for Radiation Necrosis and Local Recurrence after Proton Beam Therapy for Skull Base Chordoma or Chondrosarcoma.质子束治疗颅底脊索瘤或软骨肉瘤后放射性坏死和局部复发的危险因素
Cancers (Basel). 2023 Dec 1;15(23):5687. doi: 10.3390/cancers15235687.
2
Chondrosarcoma: A Clinical Review.软骨肉瘤:临床综述
J Clin Med. 2023 Mar 26;12(7):2506. doi: 10.3390/jcm12072506.
3
Determinants of survival in sinonasal and skull base chondrosarcoma: An analysis of the National Cancer Database.鼻窦和颅底软骨肉瘤生存的决定因素:国家癌症数据库分析
髓母细胞瘤质子束治疗与光子放疗的系统评价和荟萃分析:TRP-髓母细胞瘤2025。
Cancers (Basel). 2025 Jun 29;17(13):2191. doi: 10.3390/cancers17132191.
4
Gamma knife radiosurgery for a rare Rosette-forming glioneuronal tumor in the brainstem region: A case report and literature review.伽玛刀放射外科治疗脑干区域罕见的菊形团形成型胶质神经元肿瘤:一例报告及文献综述
Medicine (Baltimore). 2025 Mar 14;104(11):e41869. doi: 10.1097/MD.0000000000041869.
5
Proton Beam Therapy for a Rare Anaplastic Pleomorphic Xanthoastrocytoma: Case Report and Literature Review.质子束治疗罕见的间变性多形性黄色星形细胞瘤:病例报告及文献综述
Int J Part Ther. 2024 Dec 25;15:100736. doi: 10.1016/j.ijpt.2024.100736. eCollection 2025 Mar.
6
Effective local control of a giant calvarial hemangioma in a child by proton beam therapy: A case report and literature review.质子束治疗有效局部控制儿童巨大颅骨血管瘤:一例报告及文献综述
Exp Ther Med. 2024 Nov 18;29(1):14. doi: 10.3892/etm.2024.12763. eCollection 2025 Jan.
7
Late Changes in Renal Volume and Function after Proton Beam Therapy in Pediatric and Adult Patients: Children Show Significant Renal Atrophy but Deterioration of Renal Function Is Minimal in the Long-Term in Both Groups.质子束治疗后儿科和成年患者肾脏体积与功能的晚期变化:儿童出现显著肾萎缩,但两组患者长期肾功能恶化程度均最小。
Cancers (Basel). 2024 Apr 24;16(9):1634. doi: 10.3390/cancers16091634.
Int Forum Allergy Rhinol. 2022 May;12(5):699-713. doi: 10.1002/alr.22909. Epub 2021 Oct 26.
4
Particle Radiotherapy for Skull Base Chondrosarcoma: A Clinical Series from Italian National Center for Oncological Hadrontherapy.意大利国家肿瘤强子治疗中心的颅底软骨肉瘤粒子放疗:临床系列研究
Cancers (Basel). 2021 Sep 2;13(17):4423. doi: 10.3390/cancers13174423.
5
Outcomes and Patterns of Care in Adult Skull Base Chondrosarcoma Patients in the United States.美国成人颅底软骨肉瘤患者的治疗结果和治疗模式。
World Neurosurg. 2021 Jun;150:71-83. doi: 10.1016/j.wneu.2021.03.097. Epub 2021 Mar 27.
6
Dosimetric predictors of symptomatic radiation necrosis after five-fraction radiosurgery for brain metastases.五分割立体定向放射外科治疗脑转移瘤后症状性放射性坏死的剂量学预测因素。
Radiother Oncol. 2021 Mar;156:181-187. doi: 10.1016/j.radonc.2020.12.011. Epub 2020 Dec 11.
7
ESTRO ACROP guideline for target volume delineation of skull base tumors.ESTRO ACROP 颅骨底肿瘤靶区勾画指南。
Radiother Oncol. 2021 Mar;156:80-94. doi: 10.1016/j.radonc.2020.11.014. Epub 2020 Dec 10.
8
Skull Base Chordomas and Chondrosarcomas.颅底脊索瘤和软骨肉瘤。
Neuroendocrinology. 2020;110(9-10):836-847. doi: 10.1159/000509386. Epub 2020 Jun 15.
9
Outcome and Toxicity of Carbon Ion Radiotherapy for Axial Bone and Soft Tissue Sarcomas.轴向骨和软组织肉瘤碳离子放疗的结果和毒性。
Anticancer Res. 2020 May;40(5):2853-2859. doi: 10.21873/anticanres.14260.
10
How to perform a meta-analysis with R: a practical tutorial.如何使用 R 进行荟萃分析:实用教程。
Evid Based Ment Health. 2019 Nov;22(4):153-160. doi: 10.1136/ebmental-2019-300117. Epub 2019 Sep 28.